Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Nanyue Pharmaceutical is a specialized biopharmaceutical company based in China that focuses on the research, development, and production of plasma-derived therapeutics. Based in Hengyang, the company produces a comprehensive portfolio of essential blood products, including human albumin, intravenous immunoglobulin (IVIG), and coagulation factors such as Factor VIII. Originally established with military roots and later part of the Unisplendour (Ziguang) Guhan Group, it has evolved through several restructurings to become a key regional player in the Chinese blood products industry. The company operates advanced GMP-certified manufacturing facilities and maintains a network of plasma collection centers to ensure a stable supply of raw materials. Its treatments are critical for addressing conditions in hematology, immunology, and emergency medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Ziguang Huhan Nanyue Pharmaceutical.